PL205498A1 - Sposob wytwarzania pochodnych morfiny - Google Patents

Sposob wytwarzania pochodnych morfiny

Info

Publication number
PL205498A1
PL205498A1 PL20549878A PL20549878A PL205498A1 PL 205498 A1 PL205498 A1 PL 205498A1 PL 20549878 A PL20549878 A PL 20549878A PL 20549878 A PL20549878 A PL 20549878A PL 205498 A1 PL205498 A1 PL 205498A1
Authority
PL
Poland
Prior art keywords
morphine derivatives
making
making morphine
derivatives
morphine
Prior art date
Application number
PL20549878A
Other languages
English (en)
Other versions
PL114723B1 (en
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of PL205498A1 publication Critical patent/PL205498A1/pl
Publication of PL114723B1 publication Critical patent/PL114723B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL1978205498A 1977-03-23 1978-03-22 Proces for preparing novel derivatives of morphine PL114723B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB12325/77A GB1593191A (en) 1977-03-23 1977-03-23 Derivatives of morphine

Publications (2)

Publication Number Publication Date
PL205498A1 true PL205498A1 (pl) 1979-04-09
PL114723B1 PL114723B1 (en) 1981-02-28

Family

ID=10002423

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978205498A PL114723B1 (en) 1977-03-23 1978-03-22 Proces for preparing novel derivatives of morphine

Country Status (24)

Country Link
US (1) US4241066A (pl)
JP (1) JPS53119899A (pl)
AT (1) AT361139B (pl)
AU (1) AU519643B2 (pl)
BE (1) BE865183A (pl)
CA (1) CA1089456A (pl)
CH (1) CH629809A5 (pl)
CS (1) CS200542B2 (pl)
DD (1) DD133950A5 (pl)
DE (1) DE2812580A1 (pl)
DK (1) DK149858C (pl)
ES (1) ES468173A1 (pl)
FI (1) FI68236C (pl)
FR (1) FR2384774A1 (pl)
GB (1) GB1593191A (pl)
IE (1) IE46443B1 (pl)
IT (1) IT1105176B (pl)
LU (1) LU79294A1 (pl)
NL (1) NL7803083A (pl)
NZ (1) NZ186692A (pl)
PL (1) PL114723B1 (pl)
SE (1) SE436131B (pl)
SU (1) SU921467A3 (pl)
ZA (1) ZA781527B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4362870A (en) * 1980-01-16 1982-12-07 Regents Of The University Of Minnesota Selective opioid receptor alkylating agents
US4401672A (en) * 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
WO1983003197A1 (en) * 1982-03-16 1983-09-29 Univ Rockefeller Method for controlling gastrointestinal dysmotility
GB8711558D0 (en) * 1987-05-15 1987-06-17 Reckitt & Colmann Prod Ltd Derivative of codeine
ES2121988T3 (es) 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
IT1269826B (it) * 1994-05-24 1997-04-15 Paolo Minoia Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
SI2368553T1 (sl) 2003-04-08 2015-05-29 Progenics Pharmaceuticals, Inc. Farmacevtske formulacije, vsebujoče metilnatrekson
US20060063792A1 (en) * 2004-09-17 2006-03-23 Adolor Corporation Substituted morphinans and methods of their use
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AU2006259780B2 (en) 2005-06-16 2012-04-12 SpecGx LLC A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
EP2010539B1 (en) * 2006-04-21 2017-06-14 Nektar Therapeutics Stereoselective reduction of a morphinone
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
PT2139890E (pt) 2007-03-29 2014-09-03 Wyeth Llc Antagonistas do receptor opióide periférico e respectivas utilizações
EP3064503A1 (en) 2007-03-29 2016-09-07 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
CA2713568C (en) 2008-02-06 2016-09-20 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
ES2560778T3 (es) 2008-09-30 2016-02-22 Mallinckrodt Inc. Procesos para la producción de buprenorfina con formación de impurezas reducida
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
CA2738758C (en) 2008-09-30 2016-11-29 Mallinckrodt Inc. Processes for the alkylation of norbuprenorphine with reduced impurity formation
WO2015082932A1 (en) 2013-12-05 2015-06-11 The University Of Bath Novel opioid compounds and their uses
CN110330500B (zh) * 2019-07-12 2021-11-23 宜昌人福药业有限责任公司 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322771A (en) * 1967-05-30 Intermediates for preparing thebaine derivatives
US3332950A (en) * 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
BE788478A (fr) * 1971-09-08 1973-03-06 Bristol Myers Co Procede de preparation de composes analgesiques
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4089855A (en) * 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby

Also Published As

Publication number Publication date
JPS53119899A (en) 1978-10-19
AT361139B (de) 1981-02-25
NZ186692A (en) 1980-02-21
LU79294A1 (fr) 1979-10-29
ES468173A1 (es) 1979-09-16
DE2812580A1 (de) 1978-10-05
CS200542B2 (en) 1980-09-15
DK130078A (da) 1978-09-24
IT1105176B (it) 1985-10-28
US4241066A (en) 1980-12-23
AU3435778A (en) 1979-09-27
SU921467A3 (ru) 1982-04-15
DK149858B (da) 1986-10-13
DK149858C (da) 1987-06-29
AU519643B2 (en) 1981-12-17
SE7803328L (sv) 1978-09-24
FI68236B (fi) 1985-04-30
DD133950A5 (de) 1979-01-31
GB1593191A (en) 1981-07-15
IE780515L (en) 1978-09-23
SE436131B (sv) 1984-11-12
IT7848544A0 (it) 1978-03-22
CH629809A5 (fr) 1982-05-14
FI68236C (fi) 1985-08-12
ATA204278A (de) 1980-07-15
FR2384774A1 (fr) 1978-10-20
FR2384774B1 (pl) 1981-10-16
JPH0112755B2 (pl) 1989-03-02
ZA781527B (en) 1979-04-25
PL114723B1 (en) 1981-02-28
IE46443B1 (en) 1983-06-15
BE865183A (fr) 1978-09-22
CA1089456A (en) 1980-11-11
NL7803083A (nl) 1978-09-26
FI780882A (fi) 1978-09-24

Similar Documents

Publication Publication Date Title
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL205498A1 (pl) Sposob wytwarzania pochodnych morfiny
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL205497A1 (pl) Sposob wytwarzania nowych pochodnych morfiny
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL209049A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych
PL208406A1 (pl) Sposob wytwarzania pochodnych furokumaryny

Legal Events

Date Code Title Description
LICE Declarations of willingness to grant licence

Effective date: 20100119